Helicobacter pylori chronic gastritis: correlation between endoscopic findings and histopathology with special reference to updated sydney system
Abstract
Aims of the study: Helicobacter pylori (H. pylori) induces inflammatory changes in the gastric mucosa variably correlated to different endoscopic and histologic features. The present prospective study aimed to correlate different endoscopic findings with histomorphological changes and the presence of H. pylori in the gastro-duodenal mucosa, in samples of dyspeptic patients.
Methods: 60 dyspeptic patients of 18 years to 60 years of age were selected from outpatient department and screened with gastro-duodenoscopy and biopsy. The presence of H. pylori was determined by urease test on fresh biopsy specimens and histologically using the modified Giemsa stain. Findings were recorded and analyzed statistically.
Results: Highest (84.6%) H. pylori positivity was seen in the 41-50 years age group. Majority of the patients had a normal upper gastro-intestinal endoscopy; among them majority (61.2%) was positive for H. pylori infection. Most cases with endoscopic lesion in the gastro-duodenal mucosa were also positive for H. pylori infection. On biopsy, chronic gastritis was the most common (73.33%) finding in 44 cases, among them, more than two-third (70.4%) were positive for H. pylori.
Conclusion: H. pylori gastritis is strongly associated with peptic ulcer diseases, chronic gastritis and non-ulcer dyspepsia. Endoscopy and biopsy play the main role in diagnosis and identification of the spectrum of involvement.
Downloads
References
Warren, J.R. & Marshall, B.J. 1983. Unidentified curved bacillus on gastric epithelium in chronic active gastritis. Lancet.1983;1(8336):1273-1275. doi: https://doi.org/10.1016/S0140-6736(83)92719-8.
International Agency for Research on Cancer. Schistosomes, Liver flukes & H.pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 61, Lyon, France IARC 1994.
Calam J. Clinician’s guide to Helicobacter pylori. 1st ed (Chapman & Hall, London) 1996: 72-78.
ABC of Upper Gastrointestinal Tract: Epidemiology & Diagnosis of H. pylori infection-Robert PH Logan & Marjorie M Walker. BMJ 2001;323(7318):920-922. doi: https://dx.doi.org/10.1136%2Fbmj.323.7318.920.
Price AB. The Sydney system: histological division. J Gastroenterol Hepatol. 1991;6(3):209-222. doi: https://doi.org/10.1111/j.1440-1746.1991.tb01468.x.
Fiocca R, Solcia E, Santoro B. Duodenal ulcer relapse after eradication of Helicobacter pylori. The Lancet. 1991;337(8757):1614. doi: https://doi.org/10.1016/0140-6736(91)93316-2.
Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Int Med. 1992;116(9):705-708. doi: https://doi.org/10.7326/0003-4819-116-9-705.
The Eurogast Study Group: 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 341(8847):1359-1362. doi: https://doi.org/10.1016/0140-6736(93)90938-D.
Barthal JS, Everett ED. Diagnosis of Campylobacter pylori infections; The gold standard & alterations. Rev Inf Dis. 1990;12(1):S107-S114. doi: https://doi.org/10.1093/clinids/12.supplement_1.s107.
Hassan TM, Al-Najjar SI, Al-Zahrani IH, Alanazi FI, Alotibi MG. Helicobacter pylori chronic gastritis updated Sydney grading in relation to endoscopic findings and H. pylori IgG antibody: diagnostic methods. J Micros Ultrastruct. 2016;4(4):167-174. doi: https://doi.org/10.1016/j.jmau.2016.03.004.
UpendraK S, Aman G, Arun G, Arati B. Role of Helicobacter pylori in functional dyspepsia. Indian J Surg. 2004;66(6):341-346. doi: https://doi.org/10.1055/s-2005-922904.
Destura RV, Labio ED, Barrett LJ, Alcantara CS, Gloria VI, Daez ML, et al. Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines. Ann Clinic Microbiol Antimicrob. 2004;3(1):25. doi: https://dx.doi.org/10.1186%2F1476-0711-3-25.
C Vu, YY Ng. Prevalence of Helicobacter pylori in Peptic Ulcer Disease in a Singapore Hospital. Singapore Med J. 2000;41(10):478-481.
Kumar R, Bano G, Kapoor B, Sharma S, Gupta Y. Clinical Profile in H. Pylori Positive Patients in Jammu. JK Sci. 2006;8(3):148-150.
Stolte M, Edis S. Lymphoid follicles in antral mucosa: Immune response to Campylobacter pylori. J Clin Pathol 1989;42(12):1269-1271. doi: https://doi.org/10.1136/jcp.42.12.1269.
Tytgat GMJ, Rows EJ. Helicobacter pylori in duodenal and gastric ulcer disease. Bailliere’s Clin Gastroenterol 1995;9(3):529-545. doi: https://doi.org/10.1016/0950-3528(95)90047-0.
Dayal VM, Kumar P, Kamal J, Shahi SK, Agarwal BR. Triple drug therapy of H. pylori infection in duodenal ulcer disease Indian J Gastroenterol. 1997;16(2):46-48.
Prasad S, Mathew M, Chandy G, Prasanna Rajan D, Venkateswaran S, Ramakrishna BS. Prevalence of Helicobacter pylori in Southern Indian controls and patients in Gastroduodenal disease. J Gastroenterol Hepatol. 1994;9(5):501-506. doi: https://doi.org/10.1111/j.1440-1746.1994.tb01281.x.
Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 2002;17(6):659-665. doi: https://doi.org/10.1046/j.1440-1746.2002.02746.x.
Misiewicz JJ, Tytgat GN J, Goodwin C&S. The Sydney system: a new classification of gastritis. J Hepatol Gastroenterol. 1991;6(3):209-222. doi: https://doi.org/10.1111/j.1440-1746.1991.tb01467.x.
Genta RM, Dixon MF. The Sydney system revisited: the Houston international gastritis workshop. Am J Gastroenterol. 1995;90(7):1039-1041.
Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterol. 1997;113(6):551-555. doi: https://doi.org/10.1016/s0016-5085(97)80012-1.
Tabei SZ, Mojalal M, Kumar PV. Chronic gastritis associated with Helicobacter pylori infection; a histopathologic study of 200 cases. Med J Iran Hosp. 1998;1(1):11-20.
OAI - Open Archives Initiative
